Expedition, a startup searching for drugs from China, cuts its first deal
Written by
BioPharma Dive
Published
0
comments
0
min
The startup agreed to pay Fosun Pharma as much as $645 million for a drug in testing for multiple lung conditions, including bronchiectasis.